VFA
Values First Advisors Portfolio holdings
AUM
$184M
1-Year Return
18.82%
This Quarter Return
+7.03%
1 Year Return
+18.82%
3 Year Return
+69.49%
5 Year Return
+126.01%
10 Year Return
–
AUM
$184M
AUM Growth
+$17.5M
(+10%)
Cap. Flow
+$9.84M
Cap. Flow
% of AUM
5.34%
Top 10 Holdings %
Top 10 Hldgs %
28.71%
Holding
280
New
111
Increased
59
Reduced
98
Closed
8
Top Buys
| 1 |
iShares Core 1-5 Year USD Bond ETF
ISTB
|
$7.61M |
| 2 |
Vanguard Short-Term Treasury ETF
VGSH
|
$4.76M |
| 3 |
Graco
GGG
|
$2.07M |
| 4 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
$1.25M |
| 5 |
Axsome Therapeutics
AXSM
|
$568K |
Top Sells
| 1 |
iShares Short Treasury Bond ETF
SHV
|
$7.68M |
| 2 |
iShares 0-3 Month Treasury Bond ETF
SGOV
|
$4.41M |
| 3 |
Cintas
CTAS
|
$1.95M |
| 4 |
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
|
$783K |
| 5 |
Trane Technologies
TT
|
$639K |
Sector Composition
| 1 | Healthcare | 18.8% |
| 2 | Technology | 14.31% |
| 3 | Industrials | 10.88% |
| 4 | Real Estate | 7.32% |
| 5 | Consumer Discretionary | 6.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Constellation Energy
CEG
$94.2B
| $82.6K | 0.04% |
+318
| New | +$82.6K |
|
202
Cabot Corp
CBT
$4.31B
| $81.8K | 0.04% |
+732
| New | +$81.8K |
|
203
Sempra
SRE
$52.9B
| $80.8K | 0.04% |
+966
| New | +$80.8K |
|
204
NetApp
NTAP
$23.7B
| $80.5K | 0.04% |
652
-1,458
| -69% | -$180K |
|
205
Central Garden & Pet Class A
CENTA
$2.15B
| $78.9K | 0.04% |
2,511
-42
| -2% | -$1.32K |
|
206
Biohaven
BHVN
$1.68B
| $78.2K | 0.04% |
+1,565
| New | +$78.2K |
|
|
INZY
207
DELISTED
Inozyme Pharma
INZY
| $76.9K | 0.04% |
14,695
-2,372
| -14% | -$12.4K |
|
208
Relay Therapeutics
RLAY
$710M
| $74.9K | 0.04% |
+10,579
| New | +$74.9K |
|
209
IDEAYA Biosciences
IDYA
$2.38B
| $74.3K | 0.04% |
+2,345
| New | +$74.3K |
|
210
Motorola Solutions
MSI
$79.8B
| $73.8K | 0.04% |
+164
| New | +$73.8K |
|
211
Bruker
BRKR
$4.68B
| $73.2K | 0.04% |
+1,060
| New | +$73.2K |
|
212
RLI Corp
RLI
$6.16B
| $69.8K | 0.04% |
+902
| New | +$69.8K |
|
213
Eli Lilly
LLY
$652B
| $68.9K | 0.04% |
+78
| New | +$68.9K |
|
214
Lexeo Therapeutics
LXEO
$271M
| $67.3K | 0.04% |
+7,446
| New | +$67.3K |
|
215
Repligen
RGEN
$7.01B
| $62.5K | 0.03% |
+420
| New | +$62.5K |
|
216
Dyne Therapeutics
DYN
$2.02B
| $61.8K | 0.03% |
+1,720
| New | +$61.8K |
|
217
Kymera Therapeutics
KYMR
$3.11B
| $61.3K | 0.03% |
+1,296
| New | +$61.3K |
|
218
iShares Silver Trust
SLV
$20.1B
| $61.2K | 0.03% |
+2,154
| New | +$61.2K |
|
219
Sarepta Therapeutics
SRPT
$1.96B
| $58.8K | 0.03% |
+471
| New | +$58.8K |
|
220
TG Therapeutics
TGTX
$5.11B
| $58.4K | 0.03% |
+2,496
| New | +$58.4K |
|
221
Nektar Therapeutics
NKTR
$764M
| $58.2K | 0.03% |
2,984
-29
| -1% | -$566 |
|
222
VanEck Video Gaming and eSports ETF
ESPO
$437M
| $57.8K | 0.03% |
+760
| New | +$57.8K |
|
223
4D Molecular Therapeutics
FDMT
$340M
| $57.5K | 0.03% |
+5,315
| New | +$57.5K |
|
224
BridgeBio Pharma
BBIO
$10.2B
| $57K | 0.03% |
+2,237
| New | +$57K |
|
225
Coterra Energy
CTRA
$18.3B
| $56.9K | 0.03% |
+2,375
| New | +$56.9K |
|